LIVEKIDNEY.BIO

Regenerative Medicine Therapies for Kidney Disease

Health Tech & Life Sciences
Active
Seed Tel Aviv-Yafo, Israel Founded 2009
Website ↗
Last updated 2026-06-18
Total raised
$4.0M
Last: 2018-11
Stage
Seed
Founded
2009
Headcount
6
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences

About

LIVEKIDNEY.BIO is a biotechnology company developing a proprietary cell-derived delivery platform that has the potential to improve the health and life of patients while reducing the escalating economic burden of kidney disease on society. Its technology is based on sustained-release hydrogel formulations combined with AI-enabled data analytics.

The company’s novel AI-based cell-derived therapy is designed to ameliorate kidney function in patients with chronic kidney disease and to improve the general medical condition of patients with Lupus. Its promising pipeline of cell therapy-based products comprises proprietary injectable hydrogel formulations delivered via an exclusive administration route.

LIVEKIDNEY.BIO aims to prevent the progression of kidney disease, enabling kidney patients to live longer, fuller, and more productive lives.

Funding history · 1 round · $4.0M total

Q&A

What is LIVEKIDNEY.BIO's primary focus?
LIVEKIDNEY.BIO is a biotechnology company focused on regenerative medicine therapies for kidney disease, utilizing a proprietary cell-derived delivery platform.
When was LIVEKIDNEY.BIO founded?
LIVEKIDNEY.BIO was founded in November 2009.
What is the current employee count for LIVEKIDNEY.BIO?
LIVEKIDNEY.BIO has 1-10 employees.
What is LIVEKIDNEY.BIO's total funding to date?
LIVEKIDNEY.BIO has raised a total of $4,000,000.
When did LIVEKIDNEY.BIO complete its last funding round and who were the investors?
In November 2018, LIVEKIDNEY.BIO completed a funding round with investments from Aurum Ventures M.K.I and Jonathan Leitersdorf.
What technologies does LIVEKIDNEY.BIO utilize in its solutions?
LIVEKIDNEY.BIO's technology incorporates Biologicals, Cells, and Artificial Intelligence.
What is the current product stage of LIVEKIDNEY.BIO?
LIVEKIDNEY.BIO's product is currently in the clinical trial stage.
Does LIVEKIDNEY.BIO hold any patents?
Yes, LIVEKIDNEY.BIO holds one patent.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCellsArtificial Intelligence
Target customers
Healthcare & Life SciencesHealthcarePatientsLife SciencesBiotechnologyPharmaceuticals
Business model
B2B

Highlights

1 Patents

Tags

pharma-companieschronic-patientsbiotechnologymedical-technologiesstem-cellscell-therapynephrologytreatmentshospitalsdoctors
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitelivekidney.bio/

Identifiers & details

Former namesKidneyCure
Founded2009-11
Employees (exact)6

Radar intelligence

Patents

EPO2

Web history (Wayback)

Domainlivekidney.bio

Certificate / subdomain footprint

Subdomains2